XYNTHA^® Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Indication

XYNTHA is indicated for the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A.

XYNTHA does not contain von Willebrand factor and, therefore, is not indicated in von Willebrand’s disease.

XYNTHA Important Safety Information

Please see full XYNTHA Prescribing Information.

ReFacto^® Antihemophilic Factor (Recombinant) Indication

ReFacto is indicated for the control and prevention of hemorrhagic episodes and for surgical prophylaxis and for short-term routine prophylaxis to reduce the frequency of spontaneous bleeding episodes in patients with hemophilia A. The effect of regular routine prophylaxis on long-term morbidity and mortality is unknown.

ReFacto Important Safety Information

Please see full ReFacto Prescribing Information.

What Is BeneFIX^® Coagulation Factor IX (Recombinant)?

BeneFIX is an injectable medicine that is used to help control and prevent bleeding in people with hemophilia B. Hemophilia B is also called congenital factor IX deficiency or Christmas disease.

BeneFIX is NOT used to treat hemophilia A.

Selected Important Safety Information

Please see full BeneFIX Prescribing Information.